Dimorphic histopathology of long-standing childhood-onset diabetes

[1]  P. Froguel,et al.  Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes. , 2009, Pediatric endocrinology reviews : PER.

[2]  M. Peakman,et al.  Post‐mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the β cell , 2009, Clinical and experimental immunology.

[3]  M. P. Holloway,et al.  Postnatal Expansion of the Pancreatic β-Cell Mass Is Dependent on Survivin , 2008, Diabetes.

[4]  A. Foulis.  Pancreatic pathology in type 1 diabetes in human. , 2008, Novartis Foundation symposium.

[5]  Marian Rewers,et al.  The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes , 2007, Proceedings of the National Academy of Sciences.

[6]  M. Rewers,et al.  Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. , 2007, The Journal of clinical endocrinology and metabolism.

[7]  U. Bhanot,et al.  [Parenchymal regression in chronic pancreatitis spares islets reprogrammed for expression of NFkappaB and IAPs]. , 2006, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[8]  U. Bhanot,et al.  Parenchymal regression in chronic pancreatitis spares islets reprogrammed for the expression of NFκB and IAPs , 2005, Laboratory Investigation.

[9]  G. Eisenbarth,et al.  The stages of type 1A diabetes: 2005 , 2005, Immunological reviews.

[10]  M. Löhr,et al.  Residual insulin positivity and pancreatic atrophy in relation to duration of chronic Type 1 (insulin-dependent) diabetes mellitus and microangiopathy , 1987, Diabetologia.

[11]  C. Liddle,et al.  The histopathology of the pancreas in Type I (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom , 1986, Diabetologia.

[12]  Å. Lernmark,et al.  Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. , 2003, The Journal of clinical endocrinology and metabolism.

[13]  D. Orlicky,et al.  Developmentally Regulated Expression of Survivin in Human Pancreatic Islets , 2003, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[14]  Jae-Hyoung Cho,et al.  Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea , 2003 .

[15]  P. Whelton,et al.  Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. , 2003, Journal of the American Society of Nephrology : JASN.

[16]  In Kyu Lee,et al.  Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. , 2003, The Journal of clinical endocrinology and metabolism.

[17]  Neonatal diabetes mellitus due to complete glucokinase deficiency , 2001 .

[18]  G. Eisenbarth,et al.  Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction. , 1989, Clinical immunology and immunopathology.

[19]  W. Gepts.  Pathologic Anatomy of the Pancreas in Juvenile Diabetes Mellitus , 1965, Diabetes.